PLXND1 and systemic sclerosis: Accordingly, serum from patients with SSc strongly inhibited angiogenesis of H-MVECs, while the addition of Sema3E-binding PlxnD1 soluble peptide to sequester elevated Sema3E present in sera from patients with SSc significantly improved H-MVEC angiogenesis.